MedTrace Logo

Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

NCT01040741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7284

Last updated 2011-10-05

No results posted yet for this study

Summary

This is an observational safety study of a prophylactic use of Flu Egg Derived Adjuvanted Swine Origin A(H1N1) Vaccine in subjects 6 months of age and older. Subjects may receive either 1 or 2 doses: children and elderly will receive 2 doses and adults will receive either 1 or 2 doses.

Conditions

  • Pandemic Influenza A (H1N1)
  • A New Flu Virus of Swine Origin

Interventions

OTHER

Non-intervention observational study

Non-intervention observational study

Sponsors & Collaborators

  • Novartis Vaccines

    lead INDUSTRY

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Argentina
  • Netherlands

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01040741 on ClinicalTrials.gov